EICHORPublic-registry site landscape for NCT07677384, “A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder”, a Insomnia Disorder study sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07677384 (registry record) |
| Study title | A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder |
| Official title | A Multicenter, Open-label, Phase 3 Study to Evaluate the Short-term and Long-term Safety of HS-10506 in Chinese Adult Patients With Insomnia Disorder |
| Sponsor | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| Condition(s) | Insomnia Disorder |
| Phase | PHASE3 |
| Listed sites | 0 |
| Intervention(s) | HS-10506 |
Patient-friendly overview of this study: eichor.com/study/NCT07677384.
Eichor generates a preliminary site-risk snapshot for NCT07677384 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
